Daily or every other day aspirin use for secondary prevention was reported by 65%, 71%, and 57% of US adults with a history of angina, myocardial infarction, and stroke, respectively.
Cross-Sectional (n=441,456)
There are significant demographic and socioeconomic disparities in aspirin use for secondary prevention among US adults with cardiovascular disease, highlighting the need for targeted interventions to improve utilization.
= 441,456) had angina, MI, or stroke. Weighted percentages of respondents with angina, MI, and stroke were 4%, 4.3%, and 3%, respectively. Overall, weighted prevalence of daily (or every other day) aspirin use was about 65%, 71%, and 57% among respondents with angina, MI, and stroke, respectively. Factors that were significantly associated with aspirin use included male sex, more than high school education, high blood pressure, diabetes, and less than excellent general health. There were existing differences among individuals with CVD based on diagnosis, demographic and socioeconomic status in the use of aspirin for secondary prevention. Resources for promoting aspirin use should be directed toward groups with lower utilization.
Ansa et al. (Wed,) conducted a cross-sectional in Cardiovascular Disease (n=441,456). Aspirin was evaluated on Prevalence of daily (or every other day) aspirin use. Daily or every other day aspirin use for secondary prevention was reported by 65%, 71%, and 57% of US adults with a history of angina, myocardial infarction, and stroke, respectively.